The American Journal of Surgery
Volume 198, Issue 6 , Pages 781-786 , December 2009

A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo

  • Mark S. Cohen, M.D., F.A.C.S.

      Affiliations

    • Department of Surgery, University of Kansas, Medical Center, Kansas City, KS, United States
    • SC and MSC are co-first authors.
  • ,
  • Shuang Cai, M.S.

      Affiliations

    • Department of Pharmaceutical Chemistry, 2095 Constant Ave., University of Kansas, Lawrence, KS 66047, United States
    • SC and MSC are co-first authors.
  • ,
  • Yumei Xie, Ph.D.

      Affiliations

    • Department of Pharmaceutical Chemistry, 2095 Constant Ave., University of Kansas, Lawrence, KS 66047, United States
  • ,
  • M. Laird Forrest, Ph.D.

      Affiliations

    • Department of Pharmaceutical Chemistry, 2095 Constant Ave., University of Kansas, Lawrence, KS 66047, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1-785-864-4388; fax: +1-785-864-5736

Received 5 March 2009 ,Revised 2 June 2009

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by grants from NIH (R21 CA132033-01, P20 RR015563) and the American Cancer Society (RSG-08-133-01-CDD).

PII: S0002-9610(09)00554-6

doi: 10.1016/j.amjsurg.2009.07.032

The American Journal of Surgery
Volume 198, Issue 6 , Pages 781-786 , December 2009